Life Sciences

Randox is one of the thousands of UK life sciences companies whose medical products and solutions are helping the world to stay healthier for longer.

Why choose UK life sciences

Research investment
The UK is home to 4 of the world’s top 10 universities for pre-clinical, clinical and health sciences, and invests heavily in life science research.

Integrated data systems
The UK is a world leader in genomic medicine and has mapped more than 50,000 genomes in its ‘100,000 Genomes Project’.

Quality control
The UK produces safe and effective products due to a comprehensive regulatory framework with robust compliance and quality assurance.

A global centre for life sciences

The UK is a thriving centre for biomedical and healthcare innovation. It’s well placed to help the world deal with modern health challenges, including ageing populations and chronic disease.

Along with Boston and San Francisco, the UK is one of the top 3 life sciences hubs in the world. It attracts significant financing for life sciences ventures and innovation. This investment fuels a thriving cluster of life sciences businesses and a strong supply of products going through clinical trials.

The UK National Health Service (NHS) is the largest integrated healthcare system in the world. The data and clinical trial opportunities the NHS offers help to accelerate new treatments on a scale that doesn’t exist anywhere else.

Investment and a strong infrastructure have seen UK life sciences exports grow to more than £30 billion a year.

In 2016, the UK exported 48% of its life sciences manufacturing products to the EU and 52% to the rest of the world.

The UK doesn’t just export life sciences goods. We have thriving services and supply chain companies that support the development and launch of life sciences products.